PARSIPPANY, N.J., 01-17-2013 - Realogy Holdings Corp. (NYSE: RLGY), a global leader in real estate franchising and provider of real estate brokerage, relocation and settlement services, is proud to announce that it was the first company to host an open public enrollment for the American Cancer Society's Cancer Prevention Study-3 (CPS-3). The enrollment at Realogy's Parsippany headquarters was one of the American Cancer Society’s most successful, with 92 people volunteering to take part in the study.
The American Cancer Society's ultimate goal of CPS-3 is to enroll 300,000 volunteers – men and women from various racial/ethnic backgrounds from across the U.S. – to better understand the lifestyle, environmental and genetic factors that cause or prevent cancer. The first CPS discovered the link between smoking and cancer, while CPS-2 discovered the link between obesity and cancer.
"Cancer is a word heard too often in our lives. That is why fighting back against this disease with our long-time partner, Realogy, was a once-in-a-generation opportunity for Northwest New Jersey residents," said Robin Albers, regional vice president of the American Cancer Society. "Realogy is passionate about this community and committed to fighting cancer. They took on this challenge and stood apart from other corporations, Realogys dedication allowed everyone from all over the Garden State to get involved in this lifesaving cancer research."
In 2012, The CEO Roundtable on Cancer accredited Realogy with the CEO Cancer Gold Standard™ recognizing its efforts to reduce the risk of cancer for their employees and covered family members by promoting healthy lifestyle choices, encouraging early detection through cancer screenings and ensuring access to quality treatment.
"Health and wellness is a priority at Realogy, which is evidenced by our employees' positive response to the American Cancer Society's call for volunteers, and we hope other companies will follow our lead," said Dave Weaving, chief administrative officer, Realogy. "Thanks to the American Cancer Society, which has done a tremendous job organizing this study, we will most likely realize new and important discoveries to help us overcome this deadly disease."
For more information about CPS-3, visit cancer.org/cps3, email email@example.com, or call toll-free 1.888.604.5888.
The American Cancer Society combines an unyielding passion with nearly a century of experience to save lives and end suffering from cancer. As a global grassroots force of more than three million volunteers, we fight for every birthday threatened by every cancer in every community. We save lives by helping people stay well by preventing cancer or detecting it early; by helping people get well by being there for them during and after a cancer diagnosis; by finding cures through investment in groundbreaking discovery; and by fighting back by rallying lawmakers to pass laws to defeat cancer and by rallying communities worldwide to join the fight. As the nation’s largest non-governmental investor in cancer research, contributing more than $3.4 billion, we turn what we know about cancer into what we do. As a result, more than 11 million people in America who have had cancer and countless more who have avoided it will be celebrating birthdays this year. To learn more about us or to get help, call us any time, day or night, at 1-800-227-2345 or visit cancer.org.
Realogy Holdings Corp. (NYSE: RLGY) is a global leader in residential real estate franchising with company-owned residential real estate brokerage operations doing business under its franchise systems as well as relocation and title services. Realogy's brands and business units include Better Homes and Gardens® Real Estate, CENTURY 21®, Coldwell Banker®, Coldwell Banker Commercial®, The Corcoran Group®, ERA®, Sotheby's International Realty®, NRT LLC, Cartus and Title Resource Group. Collectively, Realogy's franchise system members operate approximately 13,500 offices with 239,500 independent sales associates doing business in 103 countries around the world. Realogy is headquartered in Parsippany, N.J.